Logo image of STLAP.PA

STELLANTIS NV (STLAP.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:STLAP - NL00150001Q9 - Common Stock

8.93 EUR
-0.12 (-1.29%)
Last: 11/26/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, STLAP scores 2 out of 10 in our fundamental rating. STLAP was compared to 29 industry peers in the Automobiles industry. STLAP has a bad profitability rating. Also its financial health evaluation is rather negative. STLAP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year STLAP has reported negative net income.
STLAP had a negative operating cash flow in the past year.
In the past 5 years STLAP has always been profitable.
Each year in the past 5 years STLAP had a positive operating cash flow.
STLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFSTLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.19%, STLAP is doing worse than 68.97% of the companies in the same industry.
STLAP has a Return On Equity of -3.27%. This is in the lower half of the industry: STLAP underperforms 65.52% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
STLAP.PA Yearly ROA, ROE, ROICSTLAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

STLAP's Profit Margin has declined in the last couple of years.
STLAP's Operating Margin has declined in the last couple of years.
The Gross Margin of STLAP (7.74%) is worse than 79.31% of its industry peers.
STLAP's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for STLAP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
STLAP.PA Yearly Profit, Operating, Gross MarginsSTLAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

STLAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, STLAP has less shares outstanding
STLAP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, STLAP has a worse debt to assets ratio.
STLAP.PA Yearly Shares OutstandingSTLAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
STLAP.PA Yearly Total Debt VS Total AssetsSTLAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

STLAP has an Altman-Z score of 1.35. This is a bad value and indicates that STLAP is not financially healthy and even has some risk of bankruptcy.
STLAP has a better Altman-Z score (1.35) than 65.52% of its industry peers.
STLAP has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
STLAP's Debt to Equity ratio of 0.38 is fine compared to the rest of the industry. STLAP outperforms 75.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACCN/A
WACC6.93%
STLAP.PA Yearly LT Debt VS Equity VS FCFSTLAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

STLAP has a Current Ratio of 1.06. This is a normal value and indicates that STLAP is financially healthy and should not expect problems in meeting its short term obligations.
STLAP has a Current ratio of 1.06. This is in the lower half of the industry: STLAP underperforms 65.52% of its industry peers.
STLAP has a Quick Ratio of 1.06. This is a bad value and indicates that STLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
STLAP has a worse Quick ratio (0.77) than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
STLAP.PA Yearly Current Assets VS Current LiabilitesSTLAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

STLAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.93%.
The earnings per share for STLAP have been decreasing by -15.26% on average. This is quite bad
The Revenue for STLAP has decreased by -17.07% in the past year. This is quite bad
The Revenue has been growing slightly by 7.72% on average over the past years.
EPS 1Y (TTM)-118.93%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

The Earnings Per Share is expected to grow by 5.33% on average over the next years.
The Revenue is expected to grow by 3.49% on average over the next years.
EPS Next Y-93.34%
EPS Next 2Y-18.1%
EPS Next 3Y-2.45%
EPS Next 5Y5.33%
Revenue Next Year-2.53%
Revenue Next 2Y1.26%
Revenue Next 3Y2.09%
Revenue Next 5Y3.49%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STLAP.PA Yearly Revenue VS EstimatesSTLAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
STLAP.PA Yearly EPS VS EstimatesSTLAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

STLAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 5.85 indicates a rather cheap valuation of STLAP.
86.21% of the companies in the same industry are more expensive than STLAP, based on the Price/Forward Earnings ratio.
STLAP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
Industry RankSector Rank
PE N/A
Fwd PE 5.85
STLAP.PA Price Earnings VS Forward Price EarningsSTLAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

STLAP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.93
STLAP.PA Per share dataSTLAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

STLAP's earnings are expected to decrease with -2.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.1%
EPS Next 3Y-2.45%

0

5. Dividend

5.1 Amount

No dividends for STLAP!.
Industry RankSector Rank
Dividend Yield N/A

STELLANTIS NV

EPA:STLAP (11/26/2025, 7:00:00 PM)

8.93

-0.12 (-1.29%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners50.06%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap25.86B
Revenue(TTM)146.12B
Net Income(TTM)-2.39B
Analysts68.57
Price Target9.39 (5.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.58
Dividend Growth(5Y)0.29%
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.6%
PT rev (3m)-0.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-60.8%
EPS NY rev (3m)-79.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.85
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 1.11
EV/EBITDA 6.93
EPS(TTM)-0.83
EYN/A
EPS(NY)1.53
Fwd EY17.09%
FCF(TTM)-4.68
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.46
BVpS25.25
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.77%
ROCE(5y)12.77%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.35
F-Score1
WACC6.93%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.93%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-93.34%
EPS Next 2Y-18.1%
EPS Next 3Y-2.45%
EPS Next 5Y5.33%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.53%
Revenue Next 2Y1.26%
Revenue Next 3Y2.09%
Revenue Next 5Y3.49%
EBIT growth 1Y-114.76%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year17.69%
EBIT Next 3Y26.55%
EBIT Next 5Y20.5%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%

STELLANTIS NV / STLAP.PA FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to STLAP.PA.


Can you provide the valuation status for STELLANTIS NV?

ChartMill assigns a valuation rating of 3 / 10 to STELLANTIS NV (STLAP.PA). This can be considered as Overvalued.


How profitable is STELLANTIS NV (STLAP.PA) stock?

STELLANTIS NV (STLAP.PA) has a profitability rating of 2 / 10.


What is the earnings growth outlook for STELLANTIS NV?

The Earnings per Share (EPS) of STELLANTIS NV (STLAP.PA) is expected to decline by -93.34% in the next year.